Pharma & Biotech

Investor sentiment toward Eli Lilly turned cautious last week, with the pharmaceutical giant's stock declining approximately 4.5% over a five-day...

Shares of AI-driven biotechnology firm Absci experienced significant volatility following a key development in its research pipeline. The catalyst was...

Market analysts are projecting substantial growth potential for Cullinan Oncology LLC (CLNN), with a consensus price target suggesting a potential...

Shares of genome-editing company Intellia Therapeutics closed the trading week in negative territory, continuing a period of pronounced weakness. The...

The biotechnology firm CureVac is approaching its final days as a publicly traded company on the NASDAQ. The acquisition by...

Shares of the biotechnology firm Allogene Therapeutics experienced a notable decline during the previous trading session. The move lower occurred...

While BioNTech SE achieved a major strategic objective this week, investor sentiment was dominated by emerging regulatory headwinds from the...

A dramatic power struggle is unfolding at ophthalmic device maker Staar Surgical, casting severe doubt over its pending acquisition by...

The pharmaceutical giant Teva is currently charting a remarkable recovery narrative. Having navigated years of consolidation and debt reduction, the...

Pharmaceutical titan Eli Lilly has delivered significant news on two distinct fronts, capturing investor attention. Beyond the intense spotlight on...